The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 23, 1985
Filed:
Feb. 04, 1980
Applicant:
Inventor:
Charles Weissmann, Zurich, CH;
Assignee:
Biogen N.V., Curacao, AN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12P / ; C12P / ; C12P / ; C12N / ; C12R / ; C07H / ; C12N / ; C12N / ; C12N / ; C12N / ;
U.S. Cl.
CPC ...
435 70 ; 435 68 ; 435 91 ; 4351723 ; 435240 ; 435241 ; 435253 ; 435317 ; 435317 ; 435 84 ; 435849 ; 536 27 ; 935 11 ; 935 18 ; 935 29 ; 935 60 ; 935 72 ; 935 73 ; 935 67 ; 935 68 ; 935 69 ; 935 72 ; 424 85 ;
Abstract
Recombinant DNA molecules and hosts transformed with them which produce polypeptides displaying a biological or immunological activity of human interferon, the gene coding for these polypeptides and methods of making and using these molecules, hosts, genes and polypeptides. The recombinant DNA molecules are characterized by structural genes that code for a polypeptide displaying a biological or immulogical activity of human interferon. In appropriate hosts these molecules permit the production and identification of genes and polypeptides displaying a biological or immunological activity of human interferon and their use in antiviral and antitumor or anticancer agents.